CART therapy

Two months after the first gene therapy for cancer was approved by the Food and Drug Administration, there is now another. Known as Yescarta, it will be used to treat adults with a type of non-Hodgkin lymphoma, large B-cell lymphoma, who have failed to respond to other treatments.